Search

everythinglearnresearchcommunity

for

Search:↓

Cannabinoid receptor-1 signaling is essential for the survival and growth of human hair follicle stem cells.

Gene mutations can cause problems in male genital development.

Ciclosporin can cause excessive hair growth even with testosterone blockers.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Anti-androgen therapy might help protect against COVID-19 infection and reduce death risk.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Stauntonia hexaphylla extract can help treat hair loss by blocking certain hormones.

Androgens reduce THY1 in skin cells, leading to less fat, more fibrosis, and worse healing in males.

Sex hormones might influence bladder cancer development, and aromatase inhibitors could increase risk in postmenopausal women.

Creating stronger blockers for skin enzymes might lead to better treatment for conditions like acne and excessive hair growth.

Oral antiandrogens effectively treat female hair loss, with better results in higher hair loss grades.

Hair loss needs more research for better treatments.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

Hair loss from genetics and hormones can be treated with drugs or surgery.

Antiandrogen therapy helps treat genetic hair loss.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

Sex hormones may influence COVID-19 severity, with males at higher risk, and certain hormone therapies could potentially treat the virus.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

The document concluded that FDA-approved treatments like minoxidil and finasteride are effective for hair loss, while the effectiveness of natural remedies and other non-approved treatments is not well-supported by evidence.

Extracellular vesicles and androgen receptors may help identify prostate cancer resistance and reduce SARS-CoV-2 infection.

Possible link between COVID-19 and hair loss; more research needed.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Hormones and metabolism play a complex role in prostate enlargement, and more research is needed to improve diagnosis and treatment.

Hair loss in androgenetic alopecia is caused by genetic factors and androgen excess, and can be treated with combined therapies.